AVIR — Atea Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $324.03m
- $104.56m
Brief: Atea Pharmaceuticals Q2 Basic EPS USD -0.48
Atea Pharmaceuticals Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Altus Power, Jack in the Box, Home Depot
U.S. RESEARCH ROUNDUP- Altus Power, Jack in the Box, Home Depot
Atea Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Atea Pharmaceuticals Q1 Basic EPS USD -0.75
Atea Pharmaceuticals Inc expected to post a loss of 61 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Okta, Salesforce, Sarepta Therapeutics
Atea Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Atea Pharmaceuticals Inc expected to post a loss of 50 cents a share - Earnings Preview
Brief: Atea Pharma Announces Positive Initial Data From Phase 2 Study For Hepatitis C Virus (HCV)
Atea Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Atea Pharmaceuticals Inc expected to post a loss of 47 cents a share - Earnings Preview
Brief: Atea Pharmaceuticals Announces First Patient Dosed In Phase 2 Study For Treatment Of Hepatitis C
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty
U.S. STOCKS ON THE MOVE-AI stocks, Broadcom, T2 Biosystems
Atea down after rejecting Concentra's buyout offer
Brief: Atea Pharmaceuticals' Board Of Directors Unanimously Rejects Unsolicited Proposal From Tang Capital Partners' Affiliate Concentra Biosciences
Brief: Atea Pharmaceuticals Will Review, Evaluate Proposal From Concentra Biosciences